All terms in HP

Label Id Description
Hepatic artery hyperplasia HP_4000148 [Abnormal increase in size of the hepatic arteries.]
Exacerbated by phenytoin exposure HP_4000132 [Applied to a sign or symptom that is worsened by administration of phenytoin.]
Ameliorated by vitamin D HP_4000131 [Applies to a sign or symptom that is improved or made more bearable by administration of vitamin D.]
Prostaglandin E1 exposure HP_4000134 [History of having been treateed with prostaglandin E1.]
Triggered by angiotensin-converting enzyme inhibitor HP_4000133 [Applies to a sign or symptom that is provoked or brought about by exposure to anngiotensin-converting enzyme inhibitor such as benazepril, captopril, enalapril, fosinopril, and lisinopril.]
Ameliorated by colchicine HP_4000130 [Applies to a sign or symptom that is improved or made more bearable by administration of colchizine.]
Fetal abdominal cyst HP_4000139 [Fetal abdominal cysts are usually detected during the second trimester anomaly scan or discovered incidentally at later gestations. However, a definitive diagnosis is often not made until postnatal life. The most common etiologies of fetal abdominal cysts are: ovarian, gastrointestinal cystic duplication, liver and choledochal, meconium pseudocysts, mesenteric and adrenal. Following identification of a cyst, careful morphological assessment allows the prediction of their natural history and importantly, the likelihood of surgical intervention being required postnatally.]
6-mercaptopurine exposure HP_4000136 [History of having been treateed with 6-mercaptopurine.]
antimicrobial drug CHEBI_36043 [A drug used to treat or prevent microbial infections.]
5-fluorouracil exposure HP_4000135 [History of having been treated with 5-fluorouracil.]
Absent cavum septum pellucidum HP_4000138 [The cavum septum pellucidum (CSP) is an important fetal midline forebrain landmark that is normally visible by prenatal sonography. This term refers to the lack of visibility of the CSP on prenatal sonography. The CSP normally can be visualized between 18 and 37 weeks of gestation. Lack of visualization of the CSP in this time period generally requires follow up and may indicate the presence of underlying malformations such as malformations of the corpus callosum. The lack of CSP before 18 weeks or after 37 weeks of gestation (or postnatally) is considered a normal finding.]
Isoniazid exposure HP_4000137 [History of having been treateed with isoniazid.]
Decreased circulating plasmalogen concentration HP_4000165 [Reduced plasmalogen concentration in the blood circulation.]
Reduced bifunctional protein activity HP_4000164 [Diminished activity of hydroxysteroid 17-beta dehydrogenase 4 (HSD17B4), also known as D-bifunctional protein (DBP), a peroxisomal enzyme that catalyzes multiple steps of beta-oxidation of very long chain fatty acids.]
Recent steroid exposure HP_4000167 [History of having been treated with corticosteroid medications in recent weeks.]
Post-vaccination varicella zoster virus infection HP_4000166 [Infection with live, attenuated varicella-zoster virus following vaccination. This is an extremely rare event that may indicate immunocompromise.]
Typified by low penetrance HP_4000160 [Description of conditions in which only a low proportion of individuals with a given genotype exhibit the disease regardless of age assuming a full lifespan of 80 years. There is no commonly accepted definition for low penetrance, but we suggest that this term be applied if at least some but less than 20 percent of carriers would manifest the disease with a full lifespan.]
(2S)-methylsuccinate(2-) CHEBI_191220 [The dicarboxylate anion of (S)-methylsuccinic acid; major species at pH 7.3.]
Reduced phytanic acid oxidase activity in cultured fibroblasts HP_4000163 [Activity of the enzyme phytanoyl-CoA hydroxylase (PhyH; EC 1.14.11.18) below the lower limit of normal in cultured fibroblasts. PhyH plays a role in the catabolism of phytanic acid, a branched-chain fatty acid that is a normal constituent of the human diet.]
Decreased Succinyl-CoA 3-ketoacid CoA transferase activity HP_4000162 [Decreased activity of the enzyme succinyl-CoA 3-ketoacid CoA transferase.]